Hypertension and Circulating Cytokines and Angiogenic Factors in Patients With Advanced Non-Clear Cell Renal Cell Carcinoma Treated With Sunitinib: Results From a Phase II Trial

BACKGROUND. We evaluated the significance of hypertension developing during vascular endothelial growth factor (VEGF) receptor tyrosine kinase inhibitor (VEGFR-TKI) treatment and a group of cytokines and angiogenic factors (CAFs) in advanced non-clear cell renal cell carcinoma (nccRCC) patients trea...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncologist
Main Authors: Bilen, Mehmet Asim, Zurita, Amado J., Ilias-Khan, Nasreen A., Chen, Hsiang-Chun, Wang, Xuemei, Kearney, Alper Y., Hodges, Sherie, Jonasch, Eric, Huang, Shixia, Khakoo, Aarif Yusuf, Tannir, Nizar M.
Formato: Artigo
Idioma:Inglês
Publicado em: AlphaMed Press 2015
Assuntos:
Genitourinary Cancer
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4591942/
https://ncbi.nlm.nih.gov/pubmed/26306901
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2015-0143
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados